Breaking News Instant updates and real-time market news.

MDGL

Madrigal Pharmaceuticals

$251.28

0.48 (0.19%)

04:57
08/06/18
08/06
04:57
08/06/18
04:57

Madrigal Pharmaceuticals downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs analyst Salveen Richter downgraded Madrigal Pharmaceuticals to Neutral with an unchanged price target of $314. The stock closed Friday down 41c to $250.93. The analyst continues to view MGL-3196 as a "best-in-industry, next-generation drug" for nonalcoholic steatohepatitis. However, with the stock up 173% year-to-date, he believes Madrigal is entering a "period of limited value-driving catalysts." Richter, while admitting a buyout could occur, sees limited upside in the shares.

MDGL Madrigal Pharmaceuticals
$251.28

0.48 (0.19%)

06/19/18
EVER
06/19/18
DOWNGRADE
EVER
In Line
Madrigal Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
06/19/18
06/19/18
DOWNGRADE
Target $300

In Line
Madrigal cut to In Line at Evercore ISI following run-up in price, expectations
As previously reported, Evercore ISI analyst Josh Schimmer downgraded Madrigal Pharmaceuticals (MDGL) to In Line from Outperform, stating that he has no real incremental reason to raise his $300 price target, which the stock has achieved following the company's encouraging Phase 2 results for MGL-3196 and a Bloomberg report that has driven takeover speculation. Given current investor sentiment, anything short of either an acquisition or a "massive" collaboration like Bristol-Myers' (BMY) with Nektar (NKTR) will fall short of expectations, Schimmer tells investors.
06/28/18
RAJA
06/28/18
INITIATION
RAJA
Market Perform
Madrigal Pharmaceuticals initiated with a Market Perform at Raymond James
07/12/18
CANT
07/12/18
INITIATION
Target $59
CANT
Overweight
Cantor puts $59 price target on 'undervalued' NASH play Galmed
Cantor Fitzgerald analyst Elemer Piros last night initiated coverage of Galmed Pharmaceuticals (GLMD) with an Overweight rating and $59 price target. The stock closed yesterday down 45c to $10.55. The company is developing Aramchol, a novel, once-daily, oral therapy to treat liver diseases using fattyacid/bile-acid conjugates, Piros tells investors in a research note. The analyst believes that by Q4 of 2019, only three meaningful non-alcoholic steatohepatitis pivotal programs will be in development: Allergan's (AGN) cenicriviroc, Madrigal Pharmaceuticals' (MDGL) MGL-3196, and Galmed's Aramchol. Of the three drugs, Galmed's has the highest likelihood of achieving improvement on NASH resolution without worsening of fibrosis, and improvement in fibrosis score without worsening of NASH, Piros argues. He believes Galmed is undervalued relative to peers in the NASH space.

TODAY'S FREE FLY STORIES

AMN

AMN Healthcare

$48.35

-0.895 (-1.82%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Conference/Events
AMN Healthcare management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 17

    Apr

W

Wayfair

$159.46

-11.73 (-6.85%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
03/22/19
03/22
14:15
03/22/19
14:15
General news
U.S. Treasury reported a -$234 B budget deficit for February »

U.S. Treasury reported a…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

14:13
03/22/19
03/22
14:13
03/22/19
14:13
Periodicals
Trump to withdraw new North Korea-related sanctions, CNBC says »

U.S. President Donald…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-4.92 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$123.24

-2.89 (-2.29%)

14:11
03/22/19
03/22
14:11
03/22/19
14:11
Conference/Events
Amedisys management to meet with Wiliam Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

NEM

Newmont Mining

$34.57

0.25 (0.73%)

, GG

Goldcorp

$10.71

-0.46 (-4.12%)

14:10
03/22/19
03/22
14:10
03/22/19
14:10
Periodicals
VanEck wants Newmont to renegotiate terms of Goldcorp deal, WSJ reports »

Joe Foster, who runs one…

NEM

Newmont Mining

$34.57

0.25 (0.73%)

GG

Goldcorp

$10.71

-0.46 (-4.12%)

GOLD

Barrick Gold

$13.48

0.2 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

14:10
03/22/19
03/22
14:10
03/22/19
14:10
General news
U.S. Treasury budget preview: »

U.S. Treasury budget…

AGO

Assured Guaranty

$45.19

-0.14 (-0.31%)

14:07
03/22/19
03/22
14:07
03/22/19
14:07
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 16

    Apr

  • 17

    Apr

14:03
03/22/19
03/22
14:03
03/22/19
14:03
General news
Treasury Budget data reported »

February Treasury Budget…

QCOM

Qualcomm

$57.16

-0.6 (-1.04%)

14:00
03/22/19
03/22
14:00
03/22/19
14:00
Options
Size spread in Qualcomm as shares slip »

Size spread in Qualcomm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EVER

EverQuote

$7.80

-0.1 (-1.27%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
EverQuote management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

RYTM

Rhythm Pharmaceuticals

$30.01

-0.64 (-2.09%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
Rhythm Pharmaceuticals management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TWOU

2U

$66.19

-2.92 (-4.23%)

13:57
03/22/19
03/22
13:57
03/22/19
13:57
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

GLW

Corning

$33.89

-0.91 (-2.61%)

13:55
03/22/19
03/22
13:55
03/22/19
13:55
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$2.60

-0.12 (-4.41%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Alphatec management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TLRA

Telaria

$6.16

-0.25 (-3.90%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

SRDX

Surmodics

$42.26

-3.67 (-7.99%)

13:51
03/22/19
03/22
13:51
03/22/19
13:51
Conference/Events
Surmodics management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TPR

Tapestry

$31.23

-0.72 (-2.25%)

13:49
03/22/19
03/22
13:49
03/22/19
13:49
Options
Tapestry option volume 4x normal as shares test multiyear lows »

Tapestry option volume 4x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

, RHHBY

Roche

$0.00

(0.00%)

13:46
03/22/19
03/22
13:46
03/22/19
13:46
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary  »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

13:45
03/22/19
03/22
13:45
03/22/19
13:45
General news
Treasury Budget to be reported at 14:00 »

February Treasury Budget…

SLCA

U.S. Silica

$15.90

-1.08 (-6.36%)

13:40
03/22/19
03/22
13:40
03/22/19
13:40
Options
6.3% drop in Silica motivates an upside call buyer »

6.3% drop in Silica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

SHOP

Shopify

$201.50

-3.48 (-1.70%)

13:39
03/22/19
03/22
13:39
03/22/19
13:39
Hot Stocks
Mailchimp asks to remove Shopify integration over new terms of service »

Mailchimp issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$139.28

-2.09 (-1.48%)

13:35
03/22/19
03/22
13:35
03/22/19
13:35
Options
IBM put volume heavy and directionally bearish »

Bearish flow noted in IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

PLCE

Children's Place

$86.53

-0.97 (-1.11%)

13:22
03/22/19
03/22
13:22
03/22/19
13:22
Conference/Events
Children's Place management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 02

    Apr

SPLK

Splunk

$126.05

-6.43 (-4.85%)

13:20
03/22/19
03/22
13:20
03/22/19
13:20
Options
Odd opening print in Splunk expiring contracts »

Odd opening print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 09

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.